Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder.

ABSTRACT:

Importance

Amid rapid and widespread adoption of telehealth-based opioid treatment (TBOT), there is an urgent need for rigorous studies exploring the feasibility and characteristics of urine drug screening (UDS).

Objective

To investigate administration patterns and results of UDS to assess feasibility of UDS and patient outcomes in a TBOT setting.

Design

This observational cohort study was conducted between January 1, 2021, and December 6, 2022, and included patients with opioid use disorder treated in Ophelia, a TBOT treatment platform in 14 states. Data analysis was performed from January to March 2023.

Main outcomes and measures

Number and percentage of patients with UDS within 30, 90, and 180 days of intake, grouped by adherence to clinical protocols. Assoc

SUBMITTER: Williams AR 

PROVIDER: S-EPMC10383010 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature